Glenmark Life Science’s initial public offering (IPO) will open offering from 27th July 2021 to july 29th 2021.The price band for per share has been decided to be ₹695-720 per share.
The IPO consists of a fresh issue of shares worth Rs 1,060 crore and an offer for sale of up to 6,300,000 equity shares by Glenmark Pharmaceuticals.
Goldman Sachs, Kotak Mahindra Capital, BoFa Securities, DAM Capital, BoB Caps and SBI Capital Markets are the lead managers to the issue.
The expected date to get listed in stock market is august 6.
Glenmark Life Science is a leading developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients in chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management and diabetes.